Mettler-Toledo International Inc. (NYSE:MTD) Shares Sold by Vontobel Holding Ltd.

Vontobel Holding Ltd. lessened its holdings in shares of Mettler-Toledo International Inc. (NYSE:MTDFree Report) by 64.0% in the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 8,118 shares of the medical instruments supplier’s stock after selling 14,446 shares during the quarter. Vontobel Holding Ltd.’s holdings in Mettler-Toledo International were worth $12,175,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently bought and sold shares of MTD. Capital International Investors increased its position in shares of Mettler-Toledo International by 15.1% in the first quarter. Capital International Investors now owns 1,075,420 shares of the medical instruments supplier’s stock worth $1,431,696,000 after acquiring an additional 141,431 shares in the last quarter. PineStone Asset Management Inc. boosted its position in Mettler-Toledo International by 127.4% during the 2nd quarter. PineStone Asset Management Inc. now owns 259,629 shares of the medical instruments supplier’s stock worth $362,855,000 after purchasing an additional 145,453 shares during the period. Principal Financial Group Inc. increased its holdings in Mettler-Toledo International by 2.8% in the 1st quarter. Principal Financial Group Inc. now owns 248,007 shares of the medical instruments supplier’s stock valued at $330,169,000 after purchasing an additional 6,788 shares in the last quarter. TD Asset Management Inc raised its position in Mettler-Toledo International by 1.9% in the second quarter. TD Asset Management Inc now owns 157,247 shares of the medical instruments supplier’s stock valued at $219,767,000 after purchasing an additional 2,866 shares during the period. Finally, Massachusetts Financial Services Co. MA lifted its stake in shares of Mettler-Toledo International by 32.5% during the second quarter. Massachusetts Financial Services Co. MA now owns 142,944 shares of the medical instruments supplier’s stock worth $199,777,000 after purchasing an additional 35,048 shares in the last quarter. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Insider Activity at Mettler-Toledo International

In other Mettler-Toledo International news, CFO Shawn Vadala sold 250 shares of Mettler-Toledo International stock in a transaction on Wednesday, August 7th. The shares were sold at an average price of $1,401.00, for a total value of $350,250.00. Following the completion of the transaction, the chief financial officer now owns 4,914 shares of the company’s stock, valued at $6,884,514. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link. In other Mettler-Toledo International news, CFO Shawn Vadala sold 250 shares of the firm’s stock in a transaction dated Wednesday, August 7th. The shares were sold at an average price of $1,401.00, for a total value of $350,250.00. Following the transaction, the chief financial officer now owns 4,914 shares of the company’s stock, valued at $6,884,514. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Christian Magloth sold 1,000 shares of Mettler-Toledo International stock in a transaction that occurred on Thursday, August 15th. The shares were sold at an average price of $1,422.97, for a total value of $1,422,970.00. Following the completion of the transaction, the insider now owns 734 shares of the company’s stock, valued at approximately $1,044,459.98. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.94% of the company’s stock.

Mettler-Toledo International Price Performance

NYSE MTD opened at $1,402.67 on Thursday. The company has a market capitalization of $29.96 billion, a price-to-earnings ratio of 39.33, a price-to-earnings-growth ratio of 4.24 and a beta of 1.14. Mettler-Toledo International Inc. has a 12 month low of $928.49 and a 12 month high of $1,546.93. The company’s fifty day moving average price is $1,425.70 and its two-hundred day moving average price is $1,393.19.

Mettler-Toledo International (NYSE:MTDGet Free Report) last posted its quarterly earnings results on Thursday, August 1st. The medical instruments supplier reported $9.65 EPS for the quarter, topping analysts’ consensus estimates of $9.00 by $0.65. The business had revenue of $946.75 million during the quarter, compared to the consensus estimate of $929.13 million. Mettler-Toledo International had a negative return on equity of 575.61% and a net margin of 20.95%. The company’s revenue for the quarter was down 3.6% compared to the same quarter last year. During the same period last year, the firm earned $10.19 earnings per share. As a group, analysts anticipate that Mettler-Toledo International Inc. will post 40.35 EPS for the current year.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on MTD shares. The Goldman Sachs Group increased their target price on Mettler-Toledo International from $1,150.00 to $1,300.00 and gave the company a “neutral” rating in a research note on Tuesday, July 9th. Wells Fargo & Company began coverage on shares of Mettler-Toledo International in a research report on Tuesday, August 27th. They set an “equal weight” rating and a $1,400.00 target price on the stock. JPMorgan Chase & Co. upped their target price on shares of Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the company a “neutral” rating in a research note on Monday, August 5th. StockNews.com raised shares of Mettler-Toledo International from a “hold” rating to a “buy” rating in a research note on Thursday, July 11th. Finally, Evercore ISI upped their price objective on shares of Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the company an “in-line” rating in a research report on Tuesday, October 1st. Two investment analysts have rated the stock with a sell rating, five have assigned a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $1,363.75.

Get Our Latest Analysis on Mettler-Toledo International

About Mettler-Toledo International

(Free Report)

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

Featured Articles

Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International Inc. (NYSE:MTDFree Report).

Institutional Ownership by Quarter for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.